WALPARPharmaceuticals
WALPAR NUTRITIONS — PE Ratio & Valuation Analysis
₹45.50
+0.00%
Current P/E15.96xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E148.6x89.3% below avg
✅
49.8% Discount to Industry
WALPAR P/E 15.96x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2023 | ₹0.70 | ₹83 | 118x |
| 2022 | ₹0.42 | ₹63 | 149.9x |
| 2021 | ₹0.17 | ₹29 | 177.8x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding WALPAR NUTRITIONS Valuation
WALPAR NUTRITIONS (WALPAR) currently trades at 15.96x earnings. The Pharmaceuticals sector average PE is 31.77x. WALPAR is trading at a discount to peers — may indicate relative value. Historically, WALPAR has traded at an average PE of 148.6x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
15.09%
Dividend Yield
0.00%
More on WALPAR NUTRITIONS
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.